When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
TCON - TRACON Pharma down 47% after termination of late-stage TAPPAS trial
TRACON Pharmaceuticals Inc.
TRACON Pharmaceuticals' (NASDAQ:TCON) Phase 3 TAPPAS trial evaluating TRC105 in combination with Votrient (pazopanib) in patients with advanced or metastatic angiosarcoma was terminated for futility.
More news on: TRACON Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move,